Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclooxygenase 2 inhibitors and colon cancer.

Literature DB >> 22822342

Cyclooxygenase 2 inhibitors and colon cancer.

Ana Maria Gonzalez-Angulo¹, Jyotsna Fuloria, Om Prakash.

Abstract

Entities: Disease Gene

Year: 2002 PMID： 22822342 PMCID： PMC3399281

Source DB: PubMed Journal: Ochsner J ISSN： 1524-5012

× No keyword cloud information.

22 in total

1. Aspirin use and reduced risk of fatal colon cancer.

Authors: M J Thun; M M Namboodiri; C W Heath
Journal: N Engl J Med Date: 1991-12-05 Impact factor: 91.245

2. Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas.

Authors: M Kojima; T Morisaki; A Uchiyama; F Doi; R Mibu; M Katano; M Tanaka
Journal: Ann Surg Oncol Date: 2001-06 Impact factor: 5.344

3. A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts.

Authors: C S Williams; H Sheng; J A Brockman; R Armandla; J Shao; M K Washington; A G Elkahloun; R N DuBois
Journal: Neoplasia Date: 2001 Sep-Oct Impact factor: 5.715

4. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.

Authors: H L Howe; P A Wingo; M J Thun; L A Ries; H M Rosenberg; E G Feigal; B K Edwards
Journal: J Natl Cancer Inst Date: 2001-06-06 Impact factor: 13.506

5. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.

Authors: Chinthalapally V Rao; Cooma Indranie; Barbara Simi; Pamela T Manning; Jane R Connor; Bandaru S Reddy
Journal: Cancer Res Date: 2002-01-01 Impact factor: 12.701

Cyclooxygenase 2 inhibitors and colon cancer.

1. Aspirin use and reduced risk of fatal colon cancer.

2. Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas.

3. A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts.

4. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.

5. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.

6. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.

7. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.

8. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

9. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

10. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

1. Recent publications by ochsner authors.

Review 2. Selenium Compounds as Novel Potential Anticancer Agents.

Review 3. Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors.